# LDL Receptor Under Ezetimibe and Simvastatin

> **NCT00317993** · PHASE4 · COMPLETED · sponsor: **University of Cologne** · enrollment: 60 (—)

## Conditions studied

- Healthy Men

## Interventions

- **DRUG:** ezetimibe
- **DRUG:** simvastatin
- **DRUG:** ezetimibe plus simvastatin

## Key facts

- **NCT ID:** NCT00317993
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 60 (—)
- **Last updated:** 2014-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317993, "LDL Receptor Under Ezetimibe and Simvastatin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00317993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*